Navigation Links
Proacta Incorporated and Yakult Honsha Announce Expansion of Their Collaborative Research, Development and Commercialization Agreement
Date:8/3/2011

PR610

PR509 and PR610 are Proacta's proprietary hypoxia-activated irreversible multi-kinase inhibitors discovered at the Auckland Cancer Society Research Centre, University of Auckland, New Zealand.  Reversible multi-kinase inhibitors (MKI) are currently in use for the treatment of several types of cancer.  However, resistance often develops to reversible MKI's.  In addition, reversible MKI's have side effects that limit their use at higher doses.  Both PR509 and PR610 utilize an irreversible MKI that is activated only in areas of severe hypoxia, a characteristic of most solid tumors.  Localized release of the irreversible MKI leads to higher concentrations in the tumor relative to normal tissues, which should result in improved efficacy and fewer side effects.  In addition, irreversible MKI inhibitors are not effected by some of the resistance mechanisms that limit use of reversible MKI inhibitors.

Clinical Development Status

PR509 and PR610 are currently targeted for development in non-small cell lung cancer resistant to reversible tyrosine kinase inhibitors such as erlotinib and /or gefitinib, where an effective treatment has yet to be established.  In addition to NSCLC, Proacta expects to evaluate the molecules in other cancers such as gastric, breast, and pancreatic that are currently treated with first-generation reversible tyrosine kinase inhibitors.

About Proacta Incorporated

Proacta is a San Diego based biotechnology company dedicated to the development and commercialization of hypoxia-activated oncology drugs. Proacta is currently conducting a phase II study of PR104, a hypoxia activated alkylator, in patients with relapsed or refractory leukemia.  In addition, Proacta has a pipeline of hypoxia-activated prodrugs for the treatment of cancer that are licensed from the University of Auckland in New Zealand.  For more information on Proacta, visit the Proacta web site at '/>"/>

SOURCE Proacta Incorporated; Yakult Honsha Co., Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Proacta Incorporated and Yakult Honsha Announce an Agreement for the Collaborative Research, Development and Commercialization for Proactas PR509 Compound
2. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
3. Genta Incorporated Announces Third Quarter 2007 Financial Results
4. Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights
5. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
6. ViroPharma Incorporated Completes Acquisition of Lev Pharmaceuticals
7. Mars, Incorporated Commits Over $2 Million to Federal Agency for Human-Animal Interaction Research
8. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
9. Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference
10. ViroPharma Incorporated Reports Third Quarter 2009 Financial Results
11. Quest Diagnostics Incorporated Announces Proposed Senior Notes Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 21, 2014  Zacks.com announces the list of stocks featured ... analysts discuss the latest news and events impacting stocks and ... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH - Free Report ), ... Lilly and Company (NYSE: LLY - Free Report ), ... Inc. (Nasdaq: ITMN - Free Report ). ...
(Date:7/21/2014)... Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... treatments for cancer and its associated pain, today announced ... development of a small molecule inhibitor targeting the important ... protein has also been recognized as an important determinant ... as a dominant factor in most human cancers and ...
(Date:7/21/2014)...  A new Journal of the American Medical ... to appear in the August 13 print edition addresses ... C Virus (HCV) treatments such as Sovaldi (sofosbuvir) and ... (NYSE: CVS ) Chief Medical Officer Troyen ... Shrank , M.D., suggest that the discussion to this ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 2The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 3The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 4The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 5The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 6The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 7Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 2Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 3Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 4CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 2CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 3
... INDIANAPOLIS and ROLLING MEADOWS, Ill., April 4, 2012 ... the Diabetes Scholars Foundation (Foundation) scholarship fund. The contribution ... with type 1 diabetes to live their lives to ... fund college scholarships for students with type 1 diabetes ...
... 2012   Sunpeaks Ventures, Inc. (OTCBB: SNPK) ... its wholly owned subsidiary Healthcare Distribution Specialists, LLC ... has entered into an Agreement with Albeck Financial ... Albeck will provide outsourced Chief Financial Officer services, ...
Cached Medicine Technology:Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 2Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 3Sunpeaks Ventures Announces Agreement with Albeck Financial Services 2
(Date:7/22/2014)... (PRWEB) July 22, 2014 The ... (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin ... Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast ... major drivers, restraints, challenges, opportunities, current market trends, ... along with the estimates and forecasts of the ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 For more ... and cold storage consumers with dynamic, specialized ... and customer satisfaction. Offering 50-70% less energy requirements ... process. This process is completed through a non-chemical ... technologies also provide a 4.2 Micron droplet. The ...
(Date:7/22/2014)... Rockville, Maryland (PRWEB) July 22, 2014 ... partnership with the Immune Deficiency Foundation (IDF) ... and mobile portal that will allow them to electronically ... to better manage their illnesses. It will also allow ... in research, to consent to have their data ...
(Date:7/22/2014)... Altec Products, Inc. , a ... today their Gold Sponsorship of Sage Summit 2014 ... Hotel and Casino in Las Vegas, Nevada. The largest ... interested in taking advantage of the many opportunities to ... problems and educate themselves on the latest enterprise resource ...
(Date:7/22/2014)... Tigrent Learning Canada today announced ... estate investing workshops being held in the greater Toronto, ... introduce people to some of the strategies successful investors ... total of 9 free real estate investing workshops will ... goal is to give people in the greater Toronto ...
Breaking Medicine News(10 mins):Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 2Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 3Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3Health News:Brick Buy Brick Announces Multiple 1-Day Real Estate Workshops Coming to Toronto 2
... of their breasts, can breathe easy now. They can raise ... their photographs . ,Visit www.myFreeimplants.com, set up a ... with other members. ,Once you have uploaded their ... can have a one-on-one chat online with benefactors and sell ...
... pair of legs in show business . ,But a ... hottest legs. ,Girls Aloud singer Nadine Coyle was voted ... ,The English all-girl group member beat other long-legged ladies ... singer Beyonce Knowles bagged the second place while troubled pop star ...
... Actor/producer Kirk Douglas admits that when it came to beautiful women ... ,The 90-year-old revealed that when he was young he ... with her. ,"The young Kirk was too interested in ... Post quoted Douglas, as saying. ,The actor revealed that ...
... law to ban circuses from importing or exporting protected ... rights, a legislator said Friday . ,Under ... imports and exports of animals such as lions, tigers, ... for research, said Tien Chiu-chin, of the ruling Democratic ...
... and money to properly treat a growing number of ... report out Friday . ,"The military system ... adequately support the psychological health of service members and ... year-long Pentagon mental health task force report: "An Achievable ...
... year in Sierra Leone's capital Freetown last year has been ... health worker attributed the fall in rabies cases to a ... the main referral Connaught Hospital are worried about a lack ... hospital has had to rely heavily on anti-rabies drug handouts ...
Cached Medicine News:Health News:Website Offers to Help Women Raise Money for Breast Enhancement 2Health News:War Veterans Lack Adequate Mental Health Care: Pentagon Report 2
... LV lead is designed to ensure ... procedure times, delivering a complete package ... QuickSite LV lead is a highly ... including such features as S-shaped fixation, ...
... Tibial Nail System is designed ... of existing implants and expand ... nails. It is available in ... and lengths and can be ...
Arthroscopic instrument system for instability and SLAP fixation....
Arthroscopic instrument system for instability and SLAP fixation....
Medicine Products: